» Articles » PMID: 35355864

Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage

Overview
Publisher Wiley
Date 2022 Mar 31
PMID 35355864
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Mitochondrial damage contributes to extracellular matrix (ECM) deposition and renal fibrosis. In this study, we aimed (1) to investigate whether fluorofenidone (AKF-PD) can attenuate mitochondrial damage in two renal fibrosis models: unilateral ureteral obstruction (UUO) and renal ischemia-reperfusion injury (IRI), and (2) to explore the underlying mechanism.

Method: Mitochondrial damage and renal lesions were analyzed in the UUO and IRI models. Mitochondrial energy metabolism, mitochondrial biogenesis, and oxidative stress were measured to assess the effect of AKF-PD on mitochondrial damage and to explore the underlying mechanism. In addition, HK-2 cells were stimulated with TGF- with and without AKF-PD. The mitochondrial morphology, mtROS, ATP contents, and redox-related proteins were then examined.

Results: In both UUO and IRI models, AKF-PD relieved renal fibrosis, maintained mitochondrial structure, and increased mitochondrial DNA copy numbers. The protection was associated with (1) sustaining mitochondrial energy metabolism, evident by elevations of tricarboxylic acid (TCA) cycle enzymes and mitochondrial respiratory chain complexes; (2) improving mitochondrial biogenesis with increases of TFAM, NRF1, PGC-1, and SIRT1; and (3) reducing mitochondrial oxidative stress likely via regulating SOD2, SIRT3, and NOX4 expressions. In HK-2 cells treated with TGF-, AKF-PD protected mitochondria along with improving mitochondrial morphology, enhancing ATP production, reducing mtROS, and regulating SOD2, SIRT3, and NOX4 expression.

Conclusion: We demonstrate that AKF-PD inhibited renal fibrosis at least in part via protecting mitochondria from damages developed in the UUO and IRI models. The mitochondrial protection was associated with sustaining mitochondrial energy metabolism, improving mitochondrial biogenesis, and reducing mitochondrial oxidative stress. This research verified the protective effect of AKF-PD on mitochondria in the UUO and IRI models and elaborated the underlying mechanism.

Citing Articles

ADAMTS13 attenuates renal fibrosis by suppressing thrombospondin 1 mediated TGF-β1/Smad3 activation.

Guo J, Zhou S, Wang H, Qiu X, Dong F, Jiang S Toxicol Appl Pharmacol. 2025; 496:117260.

PMID: 39929281 PMC: 11877307. DOI: 10.1016/j.taap.2025.117260.


The Role of Oxidative Stress as a Mechanism in the Pathogenesis of Acute Heart Failure in Acute Kidney Injury.

Tasic D, Dimitrijevic Z Diagnostics (Basel). 2024; 14(18).

PMID: 39335773 PMC: 11431490. DOI: 10.3390/diagnostics14182094.


Acyl-CoA thioesterase 13 () attenuates the progression of autosomal dominant polycystic kidney disease via triggering mitochondrial-related cell apoptosis.

Wang B, Yang Q, Che L, Sun L, Du N Aging (Albany NY). 2024; 16(16):11877-11892.

PMID: 39172111 PMC: 11386924. DOI: 10.18632/aging.206054.


Melanin-like nanoparticles alleviate ischemia-reperfusion injury in the kidney by scavenging reactive oxygen species and inhibiting ferroptosis.

Feng W, Zhu N, Xia Y, Huang Z, Hu J, Guo Z iScience. 2024; 27(4):109504.

PMID: 38632989 PMC: 11022057. DOI: 10.1016/j.isci.2024.109504.


Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury.

Chen Y, Li Z, Zhang H, Chen H, Hao J, Liu H Cell Death Discov. 2024; 10(1):69.

PMID: 38341438 PMC: 10858869. DOI: 10.1038/s41420-024-01843-5.


References
1.
Zhang Y, Meng X, Huang X, Lan H . The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling. Clin Sci (Lond). 2018; 132(13):1403-1415. DOI: 10.1042/CS20180243. View

2.
Mahalaxmi I, Subramaniam M, Gopalakrishnan A, Vellingiri B . Dysfunction in Mitochondrial Electron Transport Chain Complex I, Pyruvate Dehydrogenase Activity, and Mutations in ND1 and ND4 Gene in Autism Spectrum Disorder Subjects from Tamil Nadu Population, India. Mol Neurobiol. 2021; 58(10):5303-5311. DOI: 10.1007/s12035-021-02492-w. View

3.
Liu Z, Chen S, Zou Y, Wu X, Li H, Wang X . Hypochlorite modified albumins promote cell death in the tubule interstitium in rats via mitochondrial damage in obstructive nephropathy and the protective effects of antioxidant peptides. Free Radic Res. 2018; 52(5):616-628. DOI: 10.1080/10715762.2018.1457789. View

4.
Yang X, Okamura D, Lu X, Chen Y, Moorhead J, Varghese Z . CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat Rev Nephrol. 2017; 13(12):769-781. DOI: 10.1038/nrneph.2017.126. View

5.
Idelchik M, Begley U, Begley T, Melendez J . Mitochondrial ROS control of cancer. Semin Cancer Biol. 2017; 47:57-66. PMC: 5653465. DOI: 10.1016/j.semcancer.2017.04.005. View